DJIA 15,973.84 313.66 2.00%
NASDAQ 4,337.51 70.68 1.66%
S&P 500 1,864.78 35.70 1.95%
market minute promo

Novo Nordisk (NYSE: NVO)

48.80 0.18 (0.37%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

NVO $48.80 0.37%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $48.85
Previous Close $48.62
Daily Range $48.04 - $48.91
52-Week Range $42.68 - $60.34
Market Cap $129.3B
P/E Ratio 0.00
Dividend (Yield) $0.73 (1.1%)
Ex-Dividend Date
Dividend Pay Date
03/19/15
03/31/15
Volume 1,403,708
Average Daily Volume 1,676,138
Current FY EPS $2.00

Sector

Healthcare

Industry

Drug Makers

Novo Nordisk (NVO) Description

Engaged in discovery, development, manufacturing and marketing of pharmaceutical products and has two business segments - diabetes care and biopharmaceuticals. Website: http://www.novonordisk.com/

News & Commentary Rss Feed

Novo Nordisk A/S Taps the Growth Brakes

The diabetes specialist expects to see slowing operating growth, but it has a good reason.

Pre-Market Most Active for Feb 11, 2016 : MYL, CBX, TVIX, NVO, BAC, XIV, TWTR, SNY, QQQ, NOK, CSCO,

Pre-Market Most Active for Feb 11, 2016 : MYL, CBX, TVIX, NVO, BAC, XIV, TWTR, SNY, QQQ, NOK, CSCO, TLT

Benzinga's Top Downgrades

Novo Nordisk: Don't Get Scared By Foolish Investor Sentiment

Novo Nordisk Takes NASH Treatment Another Step Forward

Novo Nordisk Posts In Line Q4 Earnings, Tops Revenues

Worst Performing Industries For February 4, 2016

European ADRs Marginally Lower as Health Care Stocks Edge Down

Novo Nordisk's (NVO) CEO Lars Rebien Sorensen on Q4 2015 Results - Earnings Call Transcript

Novo Nordisk A/S (NVO) Q4 2015 Results - Earnings Call Webcast

See More NVO News...

NVO's Top Competitors

NVO $48.80 (0.37%)
Current stock: NVO
JNJ $101.82 (0.12%)
Current stock: JNJ
NVS $72.70 (0.69%)
Current stock: NVS
RHHBY $31.27 (0.42%)
Current stock: RHHBY